Company / Operating Income
KYNTRA BIO, INC. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$150.4M
FY2025
5-year range
-$322.7M / -$89.3M
FY2021-FY2025
Trend
+53.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income returned to growth in FY2025 after 4 years of decline, reaching -$150M.
Based on SEC 10-K filings.
-$150M in FY2025.
Improved from -$289M to -$150M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 53.4% year-over-year.
- Peak operating income was recorded in FY2018.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$150.4M | +53.4% |
| FY2024 | -$322.7M | -11.9% |
| FY2023 | -$288.5M | -50.4% |
| FY2022 | -$191.9M | -114.8% |
| FY2021 | -$89.3M | -3.0% |
| FY2020 | -$86.7M | +26.1% |
| FY2019 | -$117.3M | -134.4% |
| FY2018 | -$50.0M | +35.5% |
| FY2017 | -$77.6M | -54.9% |
| FY2016 | -$50.1M | -530.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026